10x Genomics is trading 4.4% down at $71.88 on October 13, as coverage cites valuation concerns and profit-taking after a substantial rally.
- The stock fell 6.77% on October 12, with no clear company-specific catalyst reported.
- XBI fell 2.01% in the regular session, a possible headwind; major U.S. indexes were nearly flat.
- Analyst sentiment remains cautious; no October 13 company-specific catalyst or trading-volume figure was confirmed.